<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: Life sciences briefing: Monday, Feb. 4, 2008</title>
	<atom:link href="http://venturebeat.com/2008/02/04/life-sciences-briefing-monday-feb-4-2008/feed/" rel="self" type="application/rss+xml" />
	<link>http://venturebeat.com/2008/02/04/life-sciences-briefing-monday-feb-4-2008/</link>
	<description>News About Tech, Money and Innovation</description>
	<lastBuildDate>Tue, 24 Nov 2009 05:47:06 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.5</generator>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
		<item>
		<title>By: uggs123</title>
		<link>http://venturebeat.com/2008/02/04/life-sciences-briefing-monday-feb-4-2008/comment-page-1/#comment-905080</link>
		<dc:creator>uggs123</dc:creator>
		<pubDate>Thu, 19 Nov 2009 07:33:29 +0000</pubDate>
		<guid isPermaLink="false">http://venturebeat.com/2008/02/04/life-sciences-briefing-monday-feb-4-2008/#comment-905080</guid>
		<description>I agree with you, Jordan is the hero of every individual mind. Of course, we are also very like the &lt;b&gt;&lt;a href=&quot;http://www.ugginlondon.co.uk/&quot; rel=&quot;nofollow&quot;&gt;ugg london&lt;/a&gt;&lt;/b&gt;    &lt;b&gt;&lt;a href=&quot;http://www.superairjordan.com/&quot; rel=&quot;nofollow&quot;&gt;air jordan shoes&lt;/a&gt;&lt;/b&gt; and &lt;b&gt;&lt;a href=&quot;http://www.topsuggboots.com/&quot; rel=&quot;nofollow&quot;&gt;ugg boots sale&lt;/a&gt;&lt;/b&gt;  . More and more people began to collect  &lt;b&gt;&lt;a href=&quot;http://www.ugginlondon.co.uk/&quot; rel=&quot;nofollow&quot;&gt;ugg boots london&lt;/a&gt;&lt;/b&gt; and  &lt;b&gt;&lt;a href=&quot;http://www.topsuggboots.com/&quot; rel=&quot;nofollow&quot;&gt;cheap ugg boots&lt;/a&gt;&lt;/b&gt; . If you are Michael Jordan fans, you must have collection &lt;b&gt;&lt;a href=&quot;http://www.superairjordan.com.com/&quot; rel=&quot;nofollow&quot;&gt;jordan shoes&lt;/a&gt;&lt;/b&gt;   &lt;b&gt;&lt;a href=&quot;http://www.myuggbootssale.com/&quot; rel=&quot;nofollow&quot;&gt;ugg boots uk&lt;/a&gt;&lt;/b&gt;   &lt;b&gt;&lt;a href=&quot;http://www.topsuggboots.com/&quot; rel=&quot;nofollow&quot;&gt;ugg boots&lt;/a&gt;&lt;/b&gt;.</description>
		<content:encoded><![CDATA[<p>I agree with you, Jordan is the hero of every individual mind. Of course, we are also very like the <b><a href="http://www.ugginlondon.co.uk/" rel="nofollow">ugg london</a></b>    <b><a href="http://www.superairjordan.com/" rel="nofollow">air jordan shoes</a></b> and <b><a href="http://www.topsuggboots.com/" rel="nofollow">ugg boots sale</a></b>  . More and more people began to collect  <b><a href="http://www.ugginlondon.co.uk/" rel="nofollow">ugg boots london</a></b> and  <b><a href="http://www.topsuggboots.com/" rel="nofollow">cheap ugg boots</a></b> . If you are Michael Jordan fans, you must have collection <b><a href="http://www.superairjordan.com.com/" rel="nofollow">jordan shoes</a></b>   <b><a href="http://www.myuggbootssale.com/" rel="nofollow">ugg boots uk</a></b>   <b><a href="http://www.topsuggboots.com/" rel="nofollow">ugg boots</a></b>.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: VentureBeat &#187; IPO roundup: Is the window slamming on life sciences?</title>
		<link>http://venturebeat.com/2008/02/04/life-sciences-briefing-monday-feb-4-2008/comment-page-1/#comment-778640</link>
		<dc:creator>VentureBeat &#187; IPO roundup: Is the window slamming on life sciences?</dc:creator>
		<pubDate>Thu, 07 Feb 2008 15:04:50 +0000</pubDate>
		<guid isPermaLink="false">http://venturebeat.com/2008/02/04/life-sciences-briefing-monday-feb-4-2008/#comment-778640</guid>
		<description>[...] maker Transoma Medical and biotechs Biolex Therapeutics and BG Medicine. (Our coverage is here, here and here.) Transoma, in fact, had set its offering terms just a few weeks earlier. All, of course, [...]</description>
		<content:encoded><![CDATA[<p>[...] maker Transoma Medical and biotechs Biolex Therapeutics and BG Medicine. (Our coverage is here, here and here.) Transoma, in fact, had set its offering terms just a few weeks earlier. All, of course, [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: VentureBeat &#187; CellGate acquired by Australian cancer biotech ProGen for $2.5M</title>
		<link>http://venturebeat.com/2008/02/04/life-sciences-briefing-monday-feb-4-2008/comment-page-1/#comment-772970</link>
		<dc:creator>VentureBeat &#187; CellGate acquired by Australian cancer biotech ProGen for $2.5M</dc:creator>
		<pubDate>Mon, 04 Feb 2008 19:51:58 +0000</pubDate>
		<guid isPermaLink="false">http://venturebeat.com/2008/02/04/life-sciences-briefing-monday-feb-4-2008/#comment-772970</guid>
		<description>[...] our story about this Redwood City, Calif., biotech in today&#8217;s daily briefing at VentureBeat Life Sciences.  Tagged N/A         VentureBeat [...]</description>
		<content:encoded><![CDATA[<p>[...] our story about this Redwood City, Calif., biotech in today&#8217;s daily briefing at VentureBeat Life Sciences.  Tagged N/A         VentureBeat [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: VentureBeat &#187; CellGate acquired by Australian cancer biotech ProGen for $2.5M</title>
		<link>http://venturebeat.com/2008/02/04/life-sciences-briefing-monday-feb-4-2008/comment-page-1/#comment-772984</link>
		<dc:creator>VentureBeat &#187; CellGate acquired by Australian cancer biotech ProGen for $2.5M</dc:creator>
		<pubDate>Mon, 04 Feb 2008 19:51:58 +0000</pubDate>
		<guid isPermaLink="false">http://venturebeat.com/2008/02/04/life-sciences-briefing-monday-feb-4-2008/#comment-772984</guid>
		<description>[...] our story about this Redwood City, Calif., biotech in today&#8217;s daily briefing at VentureBeat Life Sciences.  Tagged N/A         VentureBeat [...]</description>
		<content:encoded><![CDATA[<p>[...] our story about this Redwood City, Calif., biotech in today&#8217;s daily briefing at VentureBeat Life Sciences.  Tagged N/A         VentureBeat [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: VentureBeat &#187; CellGate acquired by Australian cancer biotech ProGen for $2.5M</title>
		<link>http://venturebeat.com/2008/02/04/life-sciences-briefing-monday-feb-4-2008/comment-page-1/#comment-772998</link>
		<dc:creator>VentureBeat &#187; CellGate acquired by Australian cancer biotech ProGen for $2.5M</dc:creator>
		<pubDate>Mon, 04 Feb 2008 19:51:58 +0000</pubDate>
		<guid isPermaLink="false">http://venturebeat.com/2008/02/04/life-sciences-briefing-monday-feb-4-2008/#comment-772998</guid>
		<description>[...] our story about this Redwood City, Calif., biotech in today&#8217;s daily briefing at VentureBeat Life Sciences.  Tagged N/A         VentureBeat [...]</description>
		<content:encoded><![CDATA[<p>[...] our story about this Redwood City, Calif., biotech in today&#8217;s daily briefing at VentureBeat Life Sciences.  Tagged N/A         VentureBeat [...]</p>
]]></content:encoded>
	</item>
</channel>
</rss>
